ATE431350T1 - Amid substituierte xanthin derivate mit gluconeogenesis modulierender wirkung - Google Patents
Amid substituierte xanthin derivate mit gluconeogenesis modulierender wirkungInfo
- Publication number
- ATE431350T1 ATE431350T1 AT03735559T AT03735559T ATE431350T1 AT E431350 T1 ATE431350 T1 AT E431350T1 AT 03735559 T AT03735559 T AT 03735559T AT 03735559 T AT03735559 T AT 03735559T AT E431350 T1 ATE431350 T1 AT E431350T1
- Authority
- AT
- Austria
- Prior art keywords
- gluconeogenesis
- xanthine derivatives
- modulating effect
- amide substituted
- substituted xanthine
- Prior art date
Links
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 title 1
- 150000001408 amides Chemical group 0.000 title 1
- 230000004110 gluconeogenesis Effects 0.000 title 1
- 229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38816402P | 2002-06-12 | 2002-06-12 | |
| PCT/EP2003/005922 WO2003106459A1 (en) | 2002-06-12 | 2003-06-05 | Amide substituted xanthine derivatives with gluconeogenesis modulating activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE431350T1 true ATE431350T1 (de) | 2009-05-15 |
Family
ID=29736437
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03735559T ATE431350T1 (de) | 2002-06-12 | 2003-06-05 | Amid substituierte xanthin derivate mit gluconeogenesis modulierender wirkung |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US7135475B2 (de) |
| EP (1) | EP1515972B1 (de) |
| JP (1) | JP4294582B2 (de) |
| KR (1) | KR100657118B1 (de) |
| CN (1) | CN100522961C (de) |
| AR (1) | AR040260A1 (de) |
| AT (1) | ATE431350T1 (de) |
| AU (1) | AU2003236702B2 (de) |
| BR (1) | BR0311760A (de) |
| CA (1) | CA2487033C (de) |
| DE (1) | DE60327628D1 (de) |
| ES (1) | ES2324215T3 (de) |
| MX (1) | MXPA04012057A (de) |
| PL (1) | PL374552A1 (de) |
| RU (1) | RU2295525C2 (de) |
| WO (1) | WO2003106459A1 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100361992C (zh) * | 2003-02-19 | 2008-01-16 | 霍夫曼-拉罗奇有限公司 | 用作pepck抑制剂的磺酰胺取代的黄嘌呤 |
| JP2006518390A (ja) * | 2003-02-19 | 2006-08-10 | エンダシア，インコーポレイテッド | Ａ１アデノシンレセプターアンタゴニスト |
| US7148229B2 (en) | 2003-02-19 | 2006-12-12 | Hoffman-La Roche Inc. | Sulfonamide substituted xanthine derivatives |
| CA2528385C (en) * | 2003-06-06 | 2011-03-15 | Endacea, Inc. | A1 adenosine receptor antogonists |
| EP1636230A4 (de) * | 2003-06-09 | 2010-06-16 | Endacea Inc | A1-adenosinrezeptorantagonisten |
| EP1716229A2 (de) | 2004-02-17 | 2006-11-02 | The University Of York | Desaturase-enzyme |
| US8318728B2 (en) | 2008-05-14 | 2012-11-27 | Hydra Biosciences, Inc. | Compounds and compositions for treating chemical warfare agent-induced injuries |
| WO2009140517A1 (en) | 2008-05-14 | 2009-11-19 | Hydra Biosciences, Inc. | Compounds and compositions for treating chemical warfare agent-induced injuries |
| KR101667063B1 (ko) * | 2008-09-02 | 2016-10-17 | 닛산 가가쿠 고교 가부시키 가이샤 | 오르토 치환 할로알킬술폰아닐리드 유도체 및 제초제 |
| WO2010132838A1 (en) * | 2009-05-14 | 2010-11-18 | Hydra Biosciences, Inc. | Compounds useful for treating disorders related to trpa1 |
| WO2012033149A1 (ja) | 2010-09-10 | 2012-03-15 | 塩野義製薬株式会社 | Ａｍｐｋ活性化作用を有するヘテロ環縮合イミダゾール誘導体 |
| KR102732697B1 (ko) * | 2021-10-29 | 2024-11-25 | 부산대학교 산학협력단 | 크산틴 유도체를 유효성분으로 포함하는 죽상동맥경화증 예방 또는 치료용 약학적 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2729642A (en) * | 1954-08-13 | 1956-01-03 | Chattanooga Medicine Co | Water soluble salts of 8-(para-aminobenzyl) caffeine and method for their preparation |
| MX9203323A (es) * | 1991-07-11 | 1994-07-29 | Hoechst Ag | El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales. |
| GB0008694D0 (en) * | 2000-04-07 | 2000-05-31 | Novartis Ag | Organic compounds |
| JP2006518390A (ja) * | 2003-02-19 | 2006-08-10 | エンダシア，インコーポレイテッド | Ａ１アデノシンレセプターアンタゴニスト |
| US7148229B2 (en) * | 2003-02-19 | 2006-12-12 | Hoffman-La Roche Inc. | Sulfonamide substituted xanthine derivatives |
| CA2528385C (en) * | 2003-06-06 | 2011-03-15 | Endacea, Inc. | A1 adenosine receptor antogonists |
-
2003
- 2003-06-05 EP EP03735559A patent/EP1515972B1/de not_active Expired - Lifetime
- 2003-06-05 CA CA002487033A patent/CA2487033C/en not_active Expired - Fee Related
- 2003-06-05 KR KR1020047020233A patent/KR100657118B1/ko not_active Expired - Fee Related
- 2003-06-05 JP JP2004513290A patent/JP4294582B2/ja not_active Expired - Fee Related
- 2003-06-05 BR BR0311760-0A patent/BR0311760A/pt not_active IP Right Cessation
- 2003-06-05 RU RU2005100761/04A patent/RU2295525C2/ru not_active IP Right Cessation
- 2003-06-05 ES ES03735559T patent/ES2324215T3/es not_active Expired - Lifetime
- 2003-06-05 MX MXPA04012057A patent/MXPA04012057A/es active IP Right Grant
- 2003-06-05 AT AT03735559T patent/ATE431350T1/de active
- 2003-06-05 PL PL03374552A patent/PL374552A1/xx not_active Application Discontinuation
- 2003-06-05 CN CNB038133180A patent/CN100522961C/zh not_active Expired - Fee Related
- 2003-06-05 WO PCT/EP2003/005922 patent/WO2003106459A1/en not_active Ceased
- 2003-06-05 DE DE60327628T patent/DE60327628D1/de not_active Expired - Lifetime
- 2003-06-05 AU AU2003236702A patent/AU2003236702B2/en not_active Ceased
- 2003-06-10 AR ARP030102068A patent/AR040260A1/es not_active Application Discontinuation
- 2003-06-12 US US10/459,944 patent/US7135475B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PL374552A1 (en) | 2005-10-31 |
| EP1515972B1 (de) | 2009-05-13 |
| KR100657118B1 (ko) | 2007-02-28 |
| ES2324215T3 (es) | 2009-08-03 |
| RU2005100761A (ru) | 2005-09-10 |
| JP4294582B2 (ja) | 2009-07-15 |
| US20040014766A1 (en) | 2004-01-22 |
| CA2487033C (en) | 2009-08-11 |
| BR0311760A (pt) | 2005-03-29 |
| CA2487033A1 (en) | 2003-12-24 |
| JP2005533067A (ja) | 2005-11-04 |
| AU2003236702B2 (en) | 2007-03-08 |
| RU2295525C2 (ru) | 2007-03-20 |
| MXPA04012057A (es) | 2005-03-07 |
| US7135475B2 (en) | 2006-11-14 |
| AU2003236702A1 (en) | 2003-12-31 |
| EP1515972A1 (de) | 2005-03-23 |
| DE60327628D1 (de) | 2009-06-25 |
| CN100522961C (zh) | 2009-08-05 |
| CN1659168A (zh) | 2005-08-24 |
| WO2003106459A1 (en) | 2003-12-24 |
| AR040260A1 (es) | 2005-03-23 |
| KR20050016548A (ko) | 2005-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE524474T1 (de) | Aminderivate mit tyrosinkinase hemmender wirkung | |
| ATE499347T1 (de) | Amidderivate | |
| DE60332125D1 (de) | Indole mit antidiabetischer wirkung | |
| FR19C1072I2 (fr) | Derive de 2-acylaminothiazole et son sel | |
| DE60325761D1 (de) | Diaminotriazole derivate und deren verwendung als protein kinase inhibitoren | |
| ATE424395T1 (de) | Aminoderivate als histone-deacetylase-inhibitoren | |
| ATE384696T1 (de) | Mandelsäure derivate | |
| ATE512965T1 (de) | Pyrrolopyrimidin derivate | |
| ATE517887T1 (de) | Neue 2-pyridincarbonsäureamidderivate | |
| ATE517888T1 (de) | Indolylmaleimid-derivate | |
| IS7433A (is) | Heteróhringlaga amíðafleiður með tálmavirkni gegnglýkógenfosfórýlasa | |
| DE60325032D1 (de) | 2-hydroxy-3-heteroarylindole derivate als gsk3 inhibitoren | |
| DK1881976T3 (da) | Substituerede amidderivater som proteinkinaseinhibitorer | |
| ATE404537T1 (de) | Heterocyclische verbindungen mit hiv-integrase- hemmender wirkung | |
| DE602004009089D1 (de) | Pyrrolderivate mit antibakterieller wirkung | |
| DE60317102D1 (de) | Pyrrolopyridazin derivate | |
| DE60333311D1 (de) | Kosmetische zusammensetzung | |
| ATE431350T1 (de) | Amid substituierte xanthin derivate mit gluconeogenesis modulierender wirkung | |
| NO20045064L (no) | Indol-, azaindol- og beslektede heterocykliske 4-alkenyl-piperidin-amider | |
| DE60311694D1 (de) | Kosmetische Zusammensetzung | |
| DK1652843T3 (da) | Amidderivater | |
| DE60113533D1 (de) | Derivate von beta-aminosäurenitrilen | |
| ATE398450T1 (de) | Derivate von aryl-chinazolin/aryl-2amino-phenyl- methanon zurförderung der freisetzung von parathormon | |
| ATE452892T1 (de) | Substituierte 8-perfluoro-6,7,8,9- tetrahydropyrimido-(1,2a) pyrimidin-4-on derivate | |
| ATE410407T1 (de) | Zimtsäureamidderivate |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1515972 Country of ref document: EP |